Fingerprint
Dive into the research topics of 'ARE N-of-1 trials an economically viable option to improve access to selected high cost medications? The Australian experience'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
ARE N-of-1 trials an economically viable option to improve access to selected high cost medications? The Australian experience
Paul A. Scuffham, Michael J. Yelland*, Jane Nikles, Eva Pietrzak, David Wilkinson
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
19
Citations
(Scopus)